Enovis Corporation ENOV
18.46
0.19
1.04%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow ENOV
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.52 | 0.57 | 0.68 | 0.78 | |
P/FCF ratio |
18.73 | 36.30 | 76.33 | 76.19 | |
P/Operating CF |
15.89 | 54.44 | 17.17 | 21.01 | |
P/B ratio |
0.81 | 0.88 | 1.02 | 0.86 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.07 | 1.14 | 1.24 | 1.37 | |
EV/EBITDA |
7.98 | 9.44 | 12.65 | 15.02 | |
EV/Operating CF |
9.12 | 10.69 | 12.80 | 14.10 | |
EV/FCF |
38.71 | 72.29 | 139.62 | 134.43 | |
Quick Ratio |
0.74 | 0.78 | 0.80 | 0.81 | |
Current Ratio |
1.98 | 2.04 | 2.02 | 2.22 | |
Net Debt/EBITDA |
14.38 | 16.18 | 16.55 | 20.61 | |
Debt/Assets |
34.11% | 34.60% | 33.82% | 30.67% | |
Debt/Equity |
0.87 | 0.90 | 0.87 | 0.67 | |
Asset Turnover |
0.52 | 0.52 | 0.53 | 0.45 | |
Operating CF/Net income |
(63.05) | (2.73) | (0.17) | (0.14) | |
Capex/Depreciation |
(0.62) | (0.72) | (0.10) | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.44% | 5.35% | 5.45% | 5.42% | |
Selling, General and Administrative Expense of Revenue |
45.25% | 48.00% | 46.97% | 48.03% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.51 | 0.56 | |
Share Based Compensation of Revenue |
1.54% | 1.49% | 1.41% | 1.59% | |
Graham Net Nets |
(0.90) | (0.85) | (0.75) | (0.65) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(93.04%) | (87.38%) | (77.74%) | (77.98%) | |
Free Cash Flow Yield |
5.34% | 2.76% | 1.31% | 1.31% | |
Revenue per Share |
10.12 | 10.28 | 10.09 | 9.60 | |
Operating CF per Share |
1.30 | 0.42 | 1.55 | 1.44 | |
Capex per Share |
(0.76) | (0.92) | (0.99) | (0.94) | |
Free Cash Flow per Share |
0.54 | (0.50) | 0.57 | 0.51 | |
Cash per Share |
0.22 | 0.58 | 0.64 | 0.59 | |
Shareholders Equity per Share |
25.68 | 25.81 | 26.14 | 35.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
25.68 | 25.81 | 26.14 | 35.40 | |
Free Cash Flow |
31.14 | (28.85) | 32.29 | 29.09 | |
Working Capital |
602.64 | 631.02 | 608.59 | 704.68 | |
Capital Expenditures |
(43.89) | (52.80) | (56.25) | (53.49) | |
Net Current Asset Value |
(1,072.27) | (1,113.08) | (1,135.78) | (1,129.56) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.08 | 0.09 | 0.10 | 0.10 | |
Net Profit Margin |
(0.20%) | (1.49%) | (90.42%) | (104.05%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
447.77 | 439.91 | 424.91 | 415.99 | |
Average Payables |
203.24 | 200.89 | 183.31 | 178.41 | |
Average Inventory |
614.94 | 594.23 | 565.75 | 611.71 | |
Average Assets |
4,393.76 | 4,353.65 | 4,276.76 | 4,991.75 | |
Average Common Equity |
2,030.06 | 2,049.86 | 2,028.12 | 2,678.49 |
Columns are period end dates